Company / Shares Outstanding
Merck & Co. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
2.5B
FY2025
5-year range
2.5B / 2.6B
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#4 of 212
Health Care
What the data says
Among 212 Health Care companies, Merck & Co. is in the bottom 2% for shares outstanding.
Based on SEC 10-K filings.
2547000000.00 in FY2025 with a 5-year CAGR of -1.0%. Top quartile in the Health Care sector.
Remained stable around 2547000000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +0.1%
- 5-Year CAGR
- -1.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 212This company 2.5B Sector average 306.7M
▼
+730.4% above sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 0.2% year-over-year.
- Ranks #4 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2016.
- Lowest shares outstanding in the period was in FY2023.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 2.5B | +0.2% |
| FY2024 | 2.5B | +0.2% |
| FY2023 | 2.5B | -0.1% |
| FY2022 | 2.5B | -1.5% |
| FY2021 | 2.6B | -3.7% |
| FY2020 | 2.7B | -2.5% |
| FY2019 | 2.7B | -1.4% |
| FY2018 | 2.8B | -1.9% |
| FY2017 | 2.8B | -3.0% |
| FY2016 | 2.9B | -2.3% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026